USE OF PROSTATIC SPECIFIC ANTIGEN AS A PREDICTOR OF THE LONG-TERM RESULTS OF BRACHYTHERAPY FOR PROSTATE CANCER

by S. A. Ivanov, E. V. Khmelevsky, S. V. Fastovets
Published 2014-08-01

USE OF PROSTATIC SPECIFIC ANTIGEN AS A PREDICTOR OF THE LONG-TERM RESULTS OF BRACHYTHERAPY FOR PROSTATE CANCER

by S. A. Ivanov, E. V. Khmelevsky, S. V. Fastovets
Published 2014-08-01

Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progres...

by R A Gafanov, S A Ivanov, S V Fastovets, T K Isaev
Published 2012-06-01

Metastatic castration-resistant prostate cancer: a current view on drug therapy and alternative tumor cell regulation

by R. A. Gafanov, S. V. Garmash, I. B. Kravtsov, S. V. Fastovets
Published 2018-04-01

MODERN POSSIBILITIES OF THERAPY WITH INHIBITORS OF CONTROL POINTS IN METASTATIC UROTHELIAL CANCER

by R. A. Gafanov, S. V. Garmash, I. B. Kravtsov, S. V. Fastovets
Published 2018-03-01

Effect of degree of differentiation of prostate cancer in long-term results of treatment

by S A Ivanov, A D Kaprin, S V Fastovets, V V Sosnovskiy
Published 2010-09-01

Metastatic hormone-sensitive prostate cancer: Practical guidelines and optimization of therapy selection

by R. A. Gafanov, A. G. Dzidzaria, I. B. Kravtsov, S. V. Fastovets
Published 2019-01-01

Choice of treatment options for metastatic hormone-sensitive prostate cancer

by R. A. Gafanov, A. G. Dzidzaria, I. B. Kravtsov, S. V. Fastovets
Published 2020-12-01

Combination of pembrolizumab and axitinib: a new gold standard in the first-line therapy for metastatic clear-cell renal-cell carcinoma?

by R. A. Gafanov, A. G. Dzidzaria, I. B. Kravtsov, S. V. Fastovets
Published 2020-11-01

The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease

by T. P. Rozina, S. V. Fastovets, E. E. Starostina, L. M. Samokhodskaya, T. N. Krasnova
Published 2018-08-01

DEGARELIX ROLE AND PLACE IN THE COMBINED TREATMENT OF PATIENTS WITH PROSTATE CANCER IN COMBINATION WITH CONCURRENT RADIOTHERAPY

by A. Y. Pavlov, R. A. Gafanov, S. V. Fastovets, A. D. Tsybulsky, T. K. Isaev
Published 2016-02-01

The first experience of non-interferon therapy of HCV infection in patients with Wilson-Konovalov’s disease

by T P Rozina, T M Ignatova, S V Fastovets, E E Starostina, L M Samokhodskaia, T N Krasnova
Published 2018-11-01

Drug treatment opportunities of the elderly patients with the metastatic castration-resistant prostate cancer

by V. A. Solodkiy, A. Yu. Pavlov, R. A. Gafanov, S. V. Garmash, I. V. Kravtsov, S. V. Fastovets, A. K. Ivashin
Published 2017-04-01